{"disease":{"id":"other-protocol-specified-criteria","name":"other protocol specified criteria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06128148","title":"Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":101,"lead_sponsor_name":"Guangzhou JOYO Pharma Co., Ltd","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}